Pharmacotherapy in Coronavirus Disease 2019 and Risk of Secondary Infections: A Single-Center Case Series and Narrative Review

OBJECTIVES: Since the onset of the coronavirus disease 2019 pandemic, immune modulators have been considered front-line candidates for the management of patients presenting with clinical symptoms secondary to severe acute respiratory syndrome coronavirus 2 infection. Although heavy emphasis has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Behal, Michael, Barlow, Brooke, Mefford, Breanne, Thompson Bastin, Melissa L., Donaldson, J. Chris, Laine, Melanie, Bissell, Brittany D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Narrative Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280010/
https://www.ncbi.nlm.nih.gov/pubmed/34278319
http://dx.doi.org/10.1097/CCE.0000000000000492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280010/
https://www.ncbi.nlm.nih.gov/pubmed/34278319
http://dx.doi.org/10.1097/CCE.0000000000000492

Ejemplares similares